Pulished Date August, 2019
ID: 2149
Share on
Share on

Asia Pacific Cancer Biomarkers Market Research Report – Segmented By Disease, Services, Application, Type, Profiling Technologies, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Analysis on Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 2149
Pages: 145

APAC Cancer Biomarkers Market Size & Growth (2019 - 2024)

The size of the Cancer Biomarkers Market in the Asia Pacific was worth USD 2.57 billion in 2019 and estimated to be growing at a CAGR of 12.6%, to reach USD 4.66 billion by 2024. The Asia-Pacific market is expected to grow at a fast pace with consistent economic development.

Cancer biomarkers are substances that are indicative of the presence of cancer in the body. With the emerging importance to quantify and validate various disease conditions, many organizations, companies, and universities have stepped forward to contribute to the field of biomarkers discovery and quantification for better prognosis of disease conditions.

The Biomarkers in the pharmaceutical industry, biomarkers in oncology & other diseases have attained utmost recognition due to the global spread of cancer and other diseases. Factors such as technological developments in omics technologies augmented demand for personalized medicines in cancer therapies and increased use of biomarkers in drug discovery development and clinical trials are anticipated to boost the growth of the cancer biomarkers market during the forecast period.

Lack of awareness about the procedure among people is restraining market growth.

APAC Cancer Biomarkers Market segmented and sub-segmented into the following categories.

  • By Disease: Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers
  • By Services: Sample Preparation, Assay Development and Biomarkers Validation And Testing
  • By Application: Risk Assessment, Development Of Molecular Diagnostics, Disease Diagnosis, Drug Discovery And Development And Drug Formulation
  • By Type: Protein Biomarkers, Genetic Biomarkers and Other Biomarkers
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

On the basis of the region, China is dominating the cancer biomarkers market and estimated to grow at the highest CAGR in the forecast period.

Key market participants in the APAC Cancer Biomarkers Market profiled in this report are Abbott Laboratories, Agendia Bv, Biocurex Inc, Biomerieux S.A., Biomoda Inc, Astellas Pharma Us Inc, Correlogic Systems Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Clarient Inc, Diadexus Inc, Ambrilia Biopharma, Affymetrix Inc and Aureon Laboratories Inc.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Disease
      1. Introduction
      2. Prostate Cancer
      3. Breast Cancer
      4. Lung Cancer
      5. Colorectal Cancer
      6. Cervical Cancer
      7. Other Cancer
      8.   Y-o-Y Growth Analysis, By Disease
      9.   Market Attractiveness Analysis, By Disease
      10.   Market Share Analysis, By Disease
    2. By Application
      1. Introduction
      2. Risk Assessment
      3. Development of molecular diagnostics
      4. Disease diagnosis
      5. Drug discovery
      6. Development and Drug formulation
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Services
      1. Sample Preparation
      2. Assay development
      3. Biomarkers validation and testing
      4. Y-o-Y Growth Analysis, By Services
      5. Market Attractiveness Analysis, By Services
      6. Market Share Analysis, By Services
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Disease
        3. By Services
        4. By Application
        5. By Type
    2. North America
      1. Introduction
      2. US
      3. Canada
      4. Mexico
      5. Rest of North America
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Turkey
      13. Czech Republic
      14. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
      7. New Zealand
      8. Thailand
      9. Malaysia
      10. Vietnam
      11. Philippines
      12. Indonesia
      13. Singapore
      14. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Chile
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. KSA
      3. UAE
      4. Israel
      5. Rest of GCC countries
      6. South Africa
      7. Ethiopia
      8. Kenya
      9. Egypt
      10. Sudan
      11. Rest of MEA
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott Laboratories
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agendia Bv
    3. Biocurex Inc.
    4. Biomerieux S.A
    5. Biomoda Inc.
    6. Astellas Pharma Us Inc.
    7. Correlogic Systems Inc.
    8. Beckman Coulter Inc.
    9. Becton Dickinson and Company
    10. Clarient Inc.
    11. Diadexus Inc.
    12. Ambrilia Biopharma
    13. Affymetrix Inc.
    14. Aureon Laboratories Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  2. Asia-Pacific Prostate Cancer Market By Region, From 2019 - 2024( USD Billion )
  3. Asia-Pacific Breast Cancer Market By Region, From 2019 - 2024( USD Billion )
  4. Asia-Pacific Lung Cancer Market By Region, From 2019 - 2024( USD Billion )
  5. Asia-Pacific Colorectal Cancer Market By Region, From 2019 - 2024( USD Billion )
  6. Asia-Pacific Cervical Cancer  Market By Region, From 2019 - 2024( USD Billion )
  7. Asia-Pacific Other Cancers Market By Region, From 2019 - 2024( USD Billion )
  8. Asia-Pacific Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  9. Asia-Pacific Sample Preparation Market By Region, From 2019 - 2024( USD Billion )
  10. Asia-Pacific Assay development  Market By Region, From 2019 - 2024( USD Billion )
  11. Asia-Pacific Biomarkers validation and testing Market By Region, From 2019 - 2024( USD Billion )
  12. Asia-Pacific Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  13. Asia-Pacific Risk Assessment Market By Region, From 2019 - 2024( USD Billion )
  14. Asia-Pacific Development of molecular diagnostics Market By Region, From 2019 - 2024( USD Billion )
  15. Asia-Pacific Disease diagnosis Market By Region, From 2019 - 2024( USD Billion )
  16. Asia-Pacific Drug discovery  Market By Region, From 2019 - 2024( USD Billion )
  17. Asia-Pacific Development and Drug formulation Market By Region, From 2019 - 2024( USD Billion )
  18. Asia-Pacific Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  19. Asia-Pacific Protein Biomarkers Market By Region, From 2019 - 2024( USD Billion )
  20. Asia-Pacific Genetic biomarkers  Market By Region, From 2019 - 2024( USD Billion )
  21. Asia-Pacific Other biomarkers Market By Region, From 2019 - 2024( USD Billion )
  22. Asia-Pacific Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  23. Asia-Pacific Omics technologies  Market By Region, From 2019 - 2024( USD Billion )
  24. Asia-Pacific Imaging technologies Market By Region, From 2019 - 2024( USD Billion )
  25. Asia-Pacific Immunoassays Market By Region, From 2019 - 2024( USD Billion )
  26. Asia-Pacific Cytogenetics Market By Region, From 2019 - 2024( USD Billion )
  27. Asia-Pacific Bioinformatics Market By Region, From 2019 - 2024( USD Billion )
  28. Asia-Pacific IVD multivariate index assays Market By Region, From 2019 - 2024( USD Billion )
  29. Japan Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  30. Japan Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  31. Japan Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  32. Japan Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  33. Japan Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  34. China Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  35. China Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  36. China Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  37. China Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  38. China Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  39. India Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  40. India Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  41. India Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  42. India Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  43. India Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  44. Australia Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  45. Australia Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  46. Australia Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  47. Australia Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  48. Australia Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  49. South Korea Cancer Biomarkers Market By Disease, From 2019 - 2024( USD Billion )
  50. South Korea Cancer Biomarkers Market By Services, From 2019 - 2024( USD Billion )
  51. South Korea Cancer Biomarkers Market By Application, From 2019 - 2024( USD Billion )
  52. South Korea Cancer Biomarkers Market By Type, From 2019 - 2024( USD Billion )
  53. South Korea Cancer Biomarkers Market By Profiling Technologies , From 2019 - 2024( USD Billion )
  54. Asia-Pacific Cancer Biomarkers Market By Omics technologies , From 2019 - 2024( USD Billion )
  55. Asia-Pacific Genomics Market By Region, From 2019 - 2024( USD Billion )
  56. Asia-Pacific Proteomics Market By Region, From 2019 - 2024( USD Billion )
  57. Asia-Pacific Metabolomics Market By Region, From 2019 - 2024( USD Billion )
  58. Asia-Pacific Transcriptomics Market By Region, From 2019 - 2024( USD Billion )
  59. Asia-Pacific Pharmacogenomics Market By Region, From 2019 - 2024( USD Billion )
  60. Japan Cancer Biomarkers Market By Omics technologies , From 2019 - 2024( USD Billion )
  61. China Cancer Biomarkers Market By Omics technologies , From 2019 - 2024( USD Billion )
  62. India Cancer Biomarkers Market By Omics technologies , From 2019 - 2024( USD Billion )
  63. Australia Cancer Biomarkers Market By Omics technologies , From 2019 - 2024( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample